WVP
ICPT

Worth Venture Partners’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Worth Venture Partners’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-38,300
Closed -$15K – 163
2021
Q4 		$15K Buy
38,300
+2,200
+6% +$37.1K 0.01% 120
2021
Q3 		$31K Buy
+36,100
New +$578K 0.01% 113
2020
Q3 		– Sell
-31,300
Closed -$20K – 143
2020
Q2 		$20K Buy
31,300
+1,000
+3% +$77.3K 0.01% 112
2020
Q1 		$76K Buy
+30,300
New +$2.72M 0.05% 91
2019
Q2 		– Sell
-91,911
Closed -$171K – 116
2019
Q1 		$171K Sell
91,911
-48,389
-34% -$5.29M 0.1% 67
2018
Q4 		$1.19M Buy
140,300
+72,000
+105% +$7.46M 0.9% 22
2018
Q3 		$355K Buy
68,300
+50,300
+279% +$5.32M 0.27% 49
2018
Q2 		$113K Buy
+18,000
New +$1.32M 0.09% 70

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return